Haier Biomedical Unveils Comprehensive Lab Solutions at analytica 2026 in Munich

Haier Biomedical, a global leader in life sciences and healthcare solutions, showcased its innovative laboratory solutions at the analytica 2026 trade fair held in Munich, Germany. The event was highlighted by the company's motto "In Europe, For Europe," which underlines its commitment to localized strategies and operations within the region. This approach is reflected in their recent accomplishments across key European markets.

Transitioning from being a traditional equipment provider to a holistic solutions provider for laboratory environments, Haier Biomedical now offers fully integrated solutions catering to biobanks, research labs, and pharmacies. Their comprehensive services cover the entire process of sample management, from collection and storage to monitoring and administration.

At analytica 2026, Haier Biomedical presented an extensive range of life science equipment, including CO₂ incubators, biological safety cabinets, centrifuges, pharmaceutical refrigerators, liquid nitrogen containers, autoclaves, and the newly launched incubator shakers designed for cell culture applications, with features like continuous shaking and precise temperature control. The focus was also on lyophilizers for effective sample drying.

One of the most notable innovations on display was the UltraEco ULT Freezer line, which uses Eco-Drive technology to achieve efficiency rates 30% higher than the industry standard. Alongside their Biobanking Solution introduced at the conference, Haier Biomedical now provides fully automated workflows for sample collection, storage, and monitoring. These advancements aim to resolve practical challenges concerning sample integrity, operational efficacy, and data traceability.

For Haier Biomedical, globalization is not merely about exporting products but rather about establishing and strengthening its presence in local markets. The company operates under a strategy called "one country, one strategy," with customized branches in 18 nations globally and over 400 local certifications obtained for their products. More than 40% of their global workforce consists of local teams, emphasizing their investment in regional expertise.

This approach has facilitated Haier Biomedical in becoming the largest market share holder among Chinese brands in six countries, including Italy, where plans are underway to set up a subsidiary to enhance local service capabilities for industrial users and offer more comprehensive services in the region.

In the UK, the company successfully completed the delivery of 64 customized biological safety cabinets to Queen Mary University of London in just 24 hours. In Italy, they delivered a tailored smart blood management system, U-Blood, to a local hospital, integrating a smart solution into the European healthcare system. Furthermore, in Germany, leading universities received Cryo-grade cryogenic freezers and BPST ULT freezers, which incorporate hydrocarbon refrigeration technology ensuring ultra-quiet operation—bolstering both research safety and efficiency.

The analytica 2026 trade fair marks a significant strategic shift for Haier Biomedical, moving from a focus on product export to co-creating an ecosystem. Through its "technology + local presence + ecosystem" model, the company is embarking on a new chapter in its pursuit of globalization in the life sciences sector.

Looking ahead, Haier Biomedical aims to solidify its foothold in the European market, relying heavily on local infrastructures while pursuing global expansion, seeking to become a trusted brand in life sciences for customers worldwide. For more information, visit Haier Medical.